Table 5. Self-reported adherence to ART based on ACTG questionnaire: effects of viral loads.
Variable | VL groups1+2 (N = 32) | VL group3 (N = 107) | P-value | |
---|---|---|---|---|
Ever missed ART because of side effects? | Never or Rarely | 23(71.88) | 98(91.59) | 0.007 |
Sometimes, Often, or has Stopped | 9(28.13) | 9(8.41) | ||
Ever missed ART because of excessive drugs? | Never or Rarely | 28(87.5) | 102(95.33) | 0.21 |
Sometimes, Often, or has Stopped | 4(12.5) | 5(4.67) | ||
Ever had difficulty taking ART at the exact time? | Never or Rarely | 23(71.88) | 91(85.05) | 0.09 |
Sometimes, Often, or has Stopped | 9(28.13) | 16(14.95) | ||
Ever missed ART (for any reason)? | Never or Rarely | 18(56.25) | 75(70.09) | 0.14 |
Sometimes, Often, or has Stopped | 14(43.75) | 32(29.91) |
Subject classification based on viral load (VL):
Group 1: High; viral load ≥ 100,000 copies /ml.
Group 2: Mid-Range; viral load >40 and <100,000 copies /ml.
Group 3: Non-detectable; viral load <40 viral copies /ml.